Skip to content
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: September 13, 2024

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

AI-Media and Speechmatics Announce Strategic Partnership to Evolve Captioning and Language Services Technologies

September 13, 2024

AI-Media and Speechmatics Partnership AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

September 13, 2024

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in

Read More
Page1 Page2 Page3 Page4 Page5
RECENT POSTS

Democratic Republic of the Congo Faces New Ebola Challenge as Schools Reopen

August 31, 2026

The Devastating Impact of Copper and Cobalt Mining Pollution in Lualaba, DRC

August 29, 2026

UN Chief Calls for Urgent Action as Ebola Cases Surge in DR Congo

August 27, 2026

African Bundibugyo Ebolavirus Vaccine Candidate to Be Advanced to Clinical Trials

August 27, 2026

Ebola Outbreak Over in Uganda but Cases Still Rising in DR Congo

August 27, 2026

100 Days of Ebola: Unprecedented Outbreak in DRC Demands Urgent Action

August 24, 2026

Democratic Republic of the Congo Marks 100 Days of Fastest Growing Ebola Outbreak

August 24, 2026

DR Congo and AFC/M23 Group Concur on Peace Negotiation Roadmap Following Swiss Talks

August 23, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.